statistiche ricercatore

PAROLARO, DANIELA

Distribuzione geografica

Continente	#
NA - Nord America	11.906
EU - Europa	7.659
AS - Asia	1.434
SA - Sud America	17
Continente sconosciuto - Info sul continente non disponibili	15
OC - Oceania	7
AF - Africa	4
Totale	21.042

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	11.867
IT - Italia	3.974
UA - Ucraina	1.450
SE - Svezia	760
TR - Turchia	613
VN - Vietnam	421
IE - Irlanda	396
CN - Cina	360
FI - Finlandia	352
DE - Germania	293
GB - Regno Unito	205
FR - Francia	100
BE - Belgio	63
CA - Canada	36
EU - Europa	15
IN - India	13
NL - Olanda	12
ES - Italia	7
BG - Bulgaria	6
BR - Brasile	6
RU - Federazione Russa	6
AU - Australia	5
CL - Cile	5
DK - Danimarca	5
PT - Portogallo	5
CH - Svizzera	4
JP - Giappone	4
PK - Pakistan	4
CO - Colombia	3
HU - Ungheria	3
MY - Malesia	3
SG - Singapore	3
AE - Emirati Arabi Uniti	2
AR - Argentina	2
GR - Grecia	2
IL - Israele	2
LT - Lituania	2
LU - Lussemburgo	2
MD - Moldavia	2
MX - Messico	2
NG - Nigeria	2
NZ - Nuova Zelanda	2
AL - Albania	1
AT - Austria	1
BT - Bhutan	1
CZ - Repubblica Ceca	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
HK - Hong Kong	1
ID - Indonesia	1
IR - Iran	1
KR - Corea	1
LA - Repubblica Popolare Democratica del Laos	1
LI - Liechtenstein	1
MA - Marocco	1
MM - Myanmar	1
MN - Mongolia	1
MT - Malta	1
NO - Norvegia	1
PA - Panama	1
PH - Filippine	1
PL - Polonia	1
RO - Romania	1
SK - Slovacchia (Repubblica Slovacca)	1
Totale	21.042

Salva come PNG Salva come JPEG

Città	#
Milan	2.817
Fairfield	1.834
Woodbridge	1.128
Jacksonville	1.099
Chandler	1.089
Ashburn	877
Houston	828
Seattle	750
Wilmington	728
Ann Arbor	659
Cambridge	607
Dublin	395
Dearborn	393
Princeton	380
Izmir	352
Nyköping	349
Rome	223
Dong Ket	218
Como	190
San Mateo	161
San Diego	88
Beijing	69
Brussels	63
Washington	59
Hefei	48
Kunming	42
Norwalk	38
London	35
Nanjing	34
Toronto	27
Ponte Lambro	23
Boardman	21
Nanchang	19
Verona	19
Guangzhou	18
Mcallen	18
Redwood City	18
Kocaeli	17
Berlin	16
Düsseldorf	16
Fuzhou	14
Falls Church	13
Jinan	13
Carbonara Al Ticino	12
Edinburgh	12
Chicago	11
Cagliari	10
Helsinki	9
Frankfurt am Main	8
Ottawa	8
Redmond	8
Shenyang	8
Varese	8
Benevento	7
Bologna	7
Chengdu	7
New York	7
Wuhan	7
Amritsar	6
Ankara	6
Istanbul	6
Prescot	6
Sofia	6
Zhengzhou	6
Auburn Hills	5
Chongqing	5
Lisbon	5
Amsterdam	4
Bollate	4
Cairate	4
Chiswick	4
Copenhagen	4
Hebei	4
Hounslow	4
Islamabad	4
Los Angeles	4
Madrid	4
Naples	4
Napoli	4
Phoenix	4
San Giuliano Milanese	4
Shanghai	4
Stuttgart	4
Villanovafranca	4
Boydton	3
Budapest	3
Changsha	3
Indiana	3
Jinhua	3
Kuala Lumpur	3
Manchester	3
Melbourne	3
Miami	3
Moscow	3
New Bedfont	3
Paris	3
Pune	3
Salerno	3
Siena	3
Simi Valley	3
Totale	16.101

Salva come PNG Salva come JPEG

Nome	#
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	240
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	216
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	213
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	195
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	194
Assay of GTPγS binding in autoradiography	189
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	188
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	188
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	186
Long lasting consequences of cannabis exposure in adolescence.	185
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	185
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	182
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	180
New vistas on cannabis use disorder	179
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	178
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	176
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	176
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	173
A molecular basis of analgesic tolerance to cannabinoids	171
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	169
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	167
Cannabinoids and opioids share cAMP pathway in rat splenocytes	165
MeCP2 related studies benefit from the use of CD1 as genetic background	163
Endocannabinoids and Mental Disorders.	162
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	158
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat	155
Role of endocannabinoids in regulating drug dependence	155
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	152
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	152
Expression and function of the endocannabinoid system in glial cells.	151
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	149
Cannabinoids and Drugs of abuse	149
The endocannabinoid system and schizophrenia: integration of evidence.	147
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	147
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	146
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	145
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	144
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	144
Molecular and cellular basis of cannabinoid and opioid interactions	142
Sex-dependent vulnerability to cannabis abuse in adolescence	142
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	141
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	141
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	140
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor.	137
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi	136
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	135
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	135
Endocannabinoids and Drug Dependence	135
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche	132
null	132
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	131
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	130
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw	130
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	130
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	130
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	130
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system	129
Cannabidiol inhibits angiogenesis by multiple mechanisms	129
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	128
The endocannabinoid system and psychiatric disorders.	128
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	127
The psychoactive ingredient of marijuana induces behavioural sensitization	126
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat	126
Binding studies of dermorphin and its L-form on rat brain opioid receptors.	126
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects	126
Endocannabinoids in the immune system and cancer	125
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	125
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	124
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.	123
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	122
Cholera toxin effects on body temperature changes induced by morphine.	122
Presence and functional regulation of cannabinoid receptors in immune cells	121
Pertussis toxin inhibits the antinociceptive action of morphine in the rat..	121
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	118
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	118
A role of nitric oxide in WIN 55,212-2 tolerance in mice.	118
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	116
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors	116
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas.	116
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.	116
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	116
Cannabinoids as potential new therapy for the treatment of gliomas.	115
Presence of a reduced opioid response in interleukin-6 knock out mice	115
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.	115
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	115
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	115
Cannabinoids, immune system and cytokine network	114
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine..	113
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system	112
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells	112
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	111
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine.	111
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.	111
Neurobiological mechanisms underlying cannabis-induced memory impairment	110
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models	109
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system	109
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	108
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.	107
Intestinal effect and analgesia: evidence for different involvement of opioid receptor subtypes in periaqueductal gray matter.	106
Is cannabinoid transmission involved in rewarding properties of drugs of abuse	105
Totale	14.118

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	52.349
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	52.349

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1.921	0	0	0	0	0	24	50	200	34	243	561	809
2019/2020	4.773	223	181	215	994	331	536	665	586	362	326	79	275
2020/2021	3.189	80	340	132	300	192	343	143	248	470	168	295	478
2021/2022	1.930	192	203	182	251	58	89	71	94	94	282	149	265
2022/2023	2.758	265	165	192	326	157	582	14	381	405	89	126	56
2023/2024	4.105	722	747	728	848	927	133	0	0	0	0	0	0
Totale													21.171